Cargando…

Detection of Active Matriptase Using a Biotinylated Chloromethyl Ketone Peptide

Matriptase is a member of the family of type II transmembrane serine proteases that is essential for development and maintenance of several epithelial tissues. Matriptase is synthesized as a single-chain zymogen precursor that is processed into a two-chain disulfide-linked form dependent on its own...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godiksen, Sine, Soendergaard, Christoffer, Friis, Stine, Jensen, Jan K., Bornholdt, Jette, Sales, Katiuchia Uzzun, Huang, Mingdong, Bugge, Thomas H., Vogel, Lotte K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799725/ https://www.ncbi.nlm.nih.gov/pubmed/24204759 http://dx.doi.org/10.1371/journal.pone.0077146

Ejemplares similares

Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis
por: Sales, Katiuchia Uzzun, et al.
Publicado: (2014)

Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
por: Szabo, Roman, et al.
Publicado: (2012)

Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors
por: Sales, Katiuchia Uzzun, et al.
Publicado: (2014)

Matriptase zymogen supports epithelial development, homeostasis and regeneration
por: Friis, Stine, et al.
Publicado: (2017)

Matriptase initiates epidermal prokallikrein activation and disease onset in a mouse model of Netherton syndrome
por: Sales, Katiuchia Uzzun, et al.
Publicado: (2010)

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
por: Bornholdt, Jette, et al.
Publicado: (2011)

Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis
por: da Silva, Elaine Zayas Marcelino, et al.
Publicado: (2021)

Rapid Construction of a Chloromethyl-Substituted Duocarmycin-like Prodrug
por: Bengtsson, Christoffer, et al.
Publicado: (2023)

Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis
por: Selzer-Plon, Joanna, et al.
Publicado: (2009)

Structure of catalytic domain of Matriptase in complex with Sunflower trypsin inhibitor-1
por: Yuan, Cai, et al.
Publicado: (2011)

Correction: Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis
por: Andersen, Vibeke, et al.
Publicado: (2013)

Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis
por: Andersen, Vibeke, et al.
Publicado: (2013)

Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer
por: Lorentzen, Anders, et al.
Publicado: (2011)

Expression and Genetic Loss of Function Analysis of the HAT/DESC Cluster Proteases TMPRSS11A and HAT
por: Sales, Katiuchia Uzzun, et al.
Publicado: (2011)

The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals
por: Vogel, Lotte K, et al.
Publicado: (2006)

Effects of a Serine Protease Inhibitor N-p-Tosyl-L-phenylalanine Chloromethyl Ketone (TPCK) on Leishmania amazonensis and Leishmania infantum
por: Machado, Patrícia de A., et al.
Publicado: (2022)

Decreasing the ratio of matriptase/HAI-1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer
por: Sun, Pengming, et al.
Publicado: (2016)

c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
por: Szabo, Roman, et al.
Publicado: (2011)

Matriptase Deletion Initiates a Sjögren’s Syndrome-Like Disease in Mice
por: Yin, Hongen, et al.
Publicado: (2014)

2-(Chloromethyl)benzimidazolium chloride
por: Wang, Gang, et al.
Publicado: (2009)

1-Chloromethyl-4-nitrobenzene
por: Aziz-ur-Rehman,, et al.
Publicado: (2010)

Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1
por: List, Karin, et al.
Publicado: (2003)

Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis
por: Kosa, Peter, et al.
Publicado: (2011)

Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity
por: Tseng, Chun-Che, et al.
Publicado: (2017)

1,6-Bis(chloromethyl)pyridine
por: Betz, Richard, et al.
Publicado: (2011)

1-Chloromethyl-3-nitrobenzene
por: Abbasi, Muhammad Athar, et al.
Publicado: (2010)

1,4-Bis(chloromethyl)naphthalene
por: Tariq, Muhammad Ilyas, et al.
Publicado: (2008)

2-Chloro-5-(chloromethyl)pyridine
por: Feng, Zhi-Qiang, et al.
Publicado: (2011)

1,3-Bis(chloromethyl)benzene
por: Sanders, Marisa B., et al.
Publicado: (2013)

Chloromethyl Glycosides as Versatile Synthons to Prepare Glycosyloxymethyl‐Prodrugs
por: Elferink, Hidde, et al.
Publicado: (2022)

Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM
por: Szabo, Roman, et al.
Publicado: (2023)

Matriptase regulates proliferation and early, but not terminal, differentiation of human keratinocytes
por: Chen, Ya-Wen, et al.
Publicado: (2013)

Diversity of Matriptase Expression Level and Function in Breast Cancer
por: Welman, Arkadiusz, et al.
Publicado: (2012)

Matriptase Autoactivation Is Tightly Regulated by the Cellular Chemical Environments
por: Wang, Jehng-Kang, et al.
Publicado: (2014)

The Impact of Acute Matriptase Inhibition in Hepatic Inflammatory Models
por: Pomothy, Judit, et al.
Publicado: (2016)

ROS is a master regulator of in vitro matriptase activation
por: Gaymon, Darius O., et al.
Publicado: (2023)

2-Chloromethyl-1-methyl-1,3-benzimidazole
por: Han, Jie, et al.
Publicado: (2011)

5-(Chloromethyl)quinolin-8-yl acetate
por: Kong, Ling-Qian, et al.
Publicado: (2008)

3-Chloromethyl-2-hydroxybenzaldehyde
por: Fu, Wei-Wei
Publicado: (2012)

Regulation of Feto-Maternal Barrier by Matriptase- and PAR-2-Mediated Signaling Is Required for Placental Morphogenesis and Mouse Embryonic Survival
por: Szabo, Roman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_84coml96ch5hean1qqlqpk7of8